TMS Therapy is FDA-cleared for Major Depression Disorder & Obsessive Compulsive Disorder after an individual has failed 1 antidepressant of a high enough dose & duration.
TMS therapy for the treatment of depression works by placing MRI-strength magnetic coil over the dorsolateral prefrontal cortex. The coil delivers magnetic pulses into the brain, activating neurons in the areas of the brain responsible for mood regulation. Pulses trigger magnetic currents that release neurotransmitters, helping with neuroplasticity without the systemic side effects that can come with medications.
TMS is non-systemic, non-invasive, and can be used as an adjunct therapy or as monotherapy, so a wide range of patients with Major Depressive Disorder can benefit from Greenbrook TMS therapy.
Typical Course of treatment for Greenbrook TMS therapy is 20-40 minutes per treatment, 5 days a week for 6 weeks & a 2-3 week treatment tapering period (average of 30 treatments total).
Once a patient has failed 2 medication trials or isn't responding as well as you'd hoped, there are other options for treatment beyond testing more medication trials. See how TMS therapy compares to electro-convulsive therapy & esketamine nasal spray.
Major findings include:
- TMS Therapy has proven durability measured over 12 months
- Medication management has limited effectiveness as trials progress
- Likelihood of discontinuing treatment because of side effects increases with each new medication attempt
Learn more with the TMS Therapy Studies fact sheet >